- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Alliance and Schering ink contrast pact
Alliance Pharmaceutical of San Diego and Schering of Berlin, Germany, last month signed an agreement in which Alliance will grant Schering licensing rights to its Imagent US ultrasound contrast agent. Imagent US is based on microbubbles that contain a
Alliance Pharmaceutical of San Diego and Schering of Berlin, Germany, last month signed an agreement in which Alliance will grant Schering licensing rights to its Imagent US ultrasound contrast agent. Imagent US is based on microbubbles that contain a mixture of perfluorochemical vapor and a physiological gas to enhance ultrasound images. It is being targeted for the assessment of cardiac function and perfusion, as well as for the detection of tumors in solid organs. The agent has completed phase II clinical studies for cardiac function.
In exchange for rights to the agent, Schering has agreed to pay licensing fees, reimburse for Alliance's R&D expenses, and purchase a minority interest in Alliance. Imagent US will complement other ultrasound agents in Schering's R&D portfolio, including Levovist and Echovist, which are on the market in some European countries but are not sold in the U.S. So far, Alliance and Imagent US have managed to avoid the recent controversy over ultrasound patents and litigation (SCAN 8/6/97).
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
